ANPEP and fibrosarcoma: In the present study we aimed at evaluating the therapeutic performance of a newly synthesised, [213Bi]Bi-labelled, NGR-motif containing radiopharmaceutical in CD13/APN-upregulated HT1080 fibrosarcoma-bearing mice.